AUTHOR=Aliakbar Raya , Manouvakhova Olga , Wong Cindy , Htut Myo , Pulst-Korenberg Johannes , Janakiram Murali , Rosenzweig Michael , Goldsmith Scott R. , Mason Xenos L. TITLE=Case report: Treatment of parkinsonism secondary to ciltacabtagene autoleucel using a combination dopaminergic regimen JOURNAL=Frontiers in Immunology VOLUME=15 YEAR=2024 URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1444010 DOI=10.3389/fimmu.2024.1444010 ISSN=1664-3224 ABSTRACT=
We report on a patient with ciltacabtagene autoleucel-induced movement and neurocognitive toxicity, which was refractory to immunosuppression but responsive to combination dopaminergic therapy (carbidopa/levodopa, ropinirole, amantadine). Response was seen upon both initial treatment and rechallenge after unintended withdrawal. This is the first report of a successful symptomatic treatment of this well-described neurotoxic syndrome.